In order to maximize the value of Pfizer products to Chinese patients and health care professional within Pfizer’s vision and mission, MA is responsible for developing China medical development and life-cycle management strategy for inline products and pipeline within Pfizer China business objectives and strategy. Provide state of the art medical expertise to assist business decision. Establish platform and channel with China academic organization in defined therapeutic area to delivery Pfizer products message to key influencers and stakeholders. Build effective medical advisor interface and provide professional medical training to support commercial teams to achieve their objectives, ensure the scientific validity and medical compliance of company activities.

1. Enhance local data generation and product life-cycle management from medical perspective to maximize product’s value and long term development under supervision.

• Evaluate new products, new indications, new research programs, new business potentials of defined therapeutic areas from medical perspective under supervision to support new product introduction and line extension.

• Align with cross function team including marketing, CCO team, global team etc, develop post marketing research strategy based on Registration/Market needs.

• Provide phase IV study direction under coaching and supervision and develop key elements.

• Design and manage local Non-interventional Study (NIS) study as a clinician.

• Develop medical strategy under supervision and implement it to support product development

• Develop publication plan and implement it.

• Evaluate and review Investigator Initiate research proposal on its scientific soundness.

1. Provide medical input to business decision making under supervision.

• Co-develop product strategy, positioning, key message with Marketing team under supervision.

• Provide medical support (topic design, KOL communication etc.) on key marketing activities.

• Provide medical insight/summary document of the defined therapeutic area to business partners to deal with key product issues such as bidding, RDL, new initiatives etc,.

• Review and approve Local Standard Response Letter to HCPs.

1. Develop sale force’s medical capability through training program design, Lecture Delivery and periodic medical knowledge update in different settings through various channel.

• At Phase I sales training

• At National sales conference

• Field visit

• Special sales force program

• Give lectures or updates to other stakeholders to increase their disease and product knowledge.

Support Drug Registration Activities:

• Timely review and approval of local product labeling (LPD).

• Develop medical justification document to support LPD related queries from government.

• Provide medical input in feasibility evaluation of studies for global trials.

• Provide official input on study site selection from therapeutic prospective.

• Provide input to registration protocol synopsis and study report as necessary.

1. Academic communication to enhance the delivery of new concept and Pfizer products key message to key influencers and stakeholders, and establish cooperation and partnership with medical association to promote medical advancement under supervision.

• Set up national level KOL database, and keep medical communication with through various approaches.

• Design educational programs for top KOLs under supervision and implement them.

• Support on China treatment guideline development, scientific interpretation and promotion

• Publish or facilitate publication of medical paper in professional journals

• Cooperation with local medical societies under supervision to conduct medical programs/conference to facilitate new concept and state of art medical progress’ introduction to China

1. In order to maintain company’s image and protect patient’s welfare, MA act as a core member to work with cross function team on crisis management under supervision.

• Perform medical evaluation, explanation on the event under supervision;

• Develop medical justification or responding document.

• Provide medical expert opinion on company responding strategy under supervision

• Review and approve all external communication documents to make sure all delivered message are medically precise and consistent.

• Communicate with external customers directly for medical issues as necessary.

1. Provide medical expert opinion in safety events management to avoid negative impact.

• Provide professional medical consultation to Safety Officer to solve Pfizer products’ safety query

• If take clinician role: provide the clinical safety oversight including performing and documenting; regular review of individual subject safety data and performing review of cumulative safety data with the safety risk lead (as delegated by the clinical lead)

• If take clinical lead role: consistent with SRP, performs and documents regular review of individual subject safety data, and performs review of cumulative safety data with the safety risk lead. As appropriate, the clinical lead may delegate these responsibilities to the study clinician identified in the SRP. The specific components of safety data review are detailed in the Safety Data Review Guide – for Clinicians and in SAF 09 SOP. For all studies, clinical safety review should be performed in consultation with a designated medical monitor if neither clinical lead nor clinicians are medically qualified.

1. Ensure company’s compliance

• Act as the sole reviewer to ensure educational grants within medical compliance under supervision

• Review and approve all promotional materials and activities to ensure their scientific standard and medical compliance with external and internal requirements

Partner with legal and regulatory colleagues to ensure high quality medical content of all promotional activities.

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

Medical